Point6 Bio

Point6 Bio is a precision diagnostics company developing the first AI-powered, biology-based blood test for early and accurate autism diagnosis. By analyzing specific biological markers in children’s plasma with proprietary machine-learning models, the test provides an objective complement to behavioral assessments that are often slow and subjective—particularly for children whose behavioral presentation differs from diagnostic norms, including girls and those from culturally or linguistically diverse backgrounds. By directly detecting autism-related molecular changes, Point6 Bio overcomes key diagnostic biases, enabling more accurate and equitable diagnosis across sexes and populations. This approach reduces diagnostic delays, supports clinicians with objective evidence, and enables personalized intervention strategies guided by biology rather than behavior.